February 2025
1. HARADA K, Sakamoto N, Kitaoka T, Nakamura Y, et al
   PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer.
   J Pathol. 2025 Feb 20. doi: 10.1002/path.6400.
   

   >> Share

   
   June 2024
2. ZHOU Y, Li S, Hu Y, Xu X, et al
   Multi-regional sequencing reveals the genetic and immune heterogeneity of non-cancerous tissues in gastric cancer.
   J Pathol. 2024 Jun 6. doi: 10.1002/path.6297.
   

   >> Share

   
   April 2024
3. MONSTER JL, Kemp LJ, Busslinger GA, Vliem MJ, et al
   Cell division-dependent dissemination following E-cadherin loss underlies initiation of diffuse-type gastric cancer.
   J Pathol. 2024 Apr 4. doi: 10.1002/path.6277.
   

   >> Share

   
   March 2024
4. DUAN S, Sawyer TW, Witten BL, Song H, et al
   Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
   J Pathol. 2024;262:362-376.
   

   >> Share

   
   June 2023
5. CHOI S, Kim H, Heo YJ, Kang SY, et al
   PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
   J Pathol. 2023 Jun 21. doi: 10.1002/path.6134.
   

   >> Share

   
   
6. ZHANG J, Chen B, Wang Y, Liu X, et al
   The E2F1-HOXB9/PBX2-CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer.
   J Pathol. 2023 Jun 5. doi: 10.1002/path.6091.
   

   >> Share

   
   May 2023
7. GOLDENRING JR
   Spasmolytic polypeptide-expressing metaplasia (SPEM) cell lineages can be an origin of gastric cancer.
   J Pathol. 2023 May 5. doi: 10.1002/path.6089.
   

   >> Share

   
   April 2023
8. YING L, Liu P, Ding Z, Wray-McCann G, et al
   Anti-CD40L therapy prevents the formation of precursor lesions to gastric B-cell MALT lymphoma in a mouse model.
   J Pathol. 2023;259:402-414.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share